Format
Sort by

Send to

Choose Destination

Search results

Items: 10

1.

HHV-6A infection induces expression of HERV-K18-encoded superantigen.

Tai AK, Luka J, Ablashi D, Huber BT.

J Clin Virol. 2009 Sep;46(1):47-8. doi: 10.1016/j.jcv.2009.05.019.

PMID:
19505843
2.

EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM.

Hsiao FC, Tai AK, Deglon A, Sutkowski N, Longnecker R, Huber BT.

Virology. 2009 Mar 1;385(1):261-6. doi: 10.1016/j.virol.2008.11.025.

3.

Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.

Tai AK, O'Reilly EJ, Alroy KA, Simon KC, Munger KL, Huber BT, Ascherio A.

Mult Scler. 2008 Nov;14(9):1175-80. doi: 10.1177/1352458508094641.

4.
5.
6.

Defective B cell responses in the absence of SH2D1A.

Morra M, Barrington RA, Abadia-Molina AC, Okamoto S, Julien A, Gullo C, Kalsy A, Edwards MJ, Chen G, Spolski R, Leonard WJ, Huber BT, Borrow P, Biron CA, Satoskar AR, Carroll MC, Terhorst C.

Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4819-23.

8.

Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.

Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT.

Immunity. 2001 Oct;15(4):579-89.

9.

An Epstein-Barr virus-associated superantigen.

Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT.

J Exp Med. 1996 Sep 1;184(3):971-80.

10.

Virus-encoded superantigens.

Huber BT, Hsu PN, Sutkowski N.

Microbiol Rev. 1996 Sep;60(3):473-82. Review.

Items per page

Supplemental Content

Loading ...
Support Center